SARS-CoV-2 Neutralizing Antibody Rapid Test

Biotime SARS-CoV-2 Neutralizing Antibody rapid test is a fluorescence immunoassay(FIA) for the qualitative detection of total neutralizing antibodies to SARS-CoV-2 in human serum or plasma. It is useful as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

SARS-CoV-2 IgG/IgM Rapid Qualitative Test

The Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test is intended to qualify the SARS-CoV-2 IgG and IgM antibody in human plasma, serum or whole blood by colloidal gold immunochromatography assay. The test can be used as an aid detection to SARS-CoV-2 infection and thus caused COVID-19 disease.

SARS-CoV-2 Antigen Rapid Qualitative Test

The SARS-CoV-2 Antigen Rapid Qualitative Test is a colloidal gold immunochromatography intended for the qualitative detection of nucleocapsid antigens from SARS-CoV-2 in human nasal swabs, throat swabs, and sputum from individuals who are suspected of COVID-19 by their healthcare provider. within the first five days of the onset of symptoms.

TSH Rapid Quantitative Test(Chemiluminescence Immunoassay)

TSH Rapid Quantitative Test(Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the thyroid stimulating hormone concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of thyroid diseases.

HbA1c Rapid Quantitative Test

HbA1c is the product of the hemoglobin combining with blood glucose in red blood cells, which can reflect the average blood glucose level over the amid 2-3 months.

H. Pylori Antigen Qualitative Test（Fluorescence Immunoassay）

The Biotime Helicobacter pylori (H.pylori) Antigen Rapid Test is intended to qualitatively detect the Helicobacter pylori (H.pylori) antigen in human faeces samples on Biotime FIA Analyzer by fluorescent immunoassay. The test is used as an early aid diagnosis and screening of Helicobacter pylori infection. For in vitro diagnostic use only. For professional use only.

RF Rapid Quantitative Test (Fluorescence Immunoassay)

The Biotime RF Rapid Quantitative Test is intended to quantify the concentration of RF in human serum, plasma, and whole blood on the Biotime FIA Analyzer by fluorescent immunoassay. The test is used as an aid in the detection of rheumatoid arthritis. -Fluorescence immunoassay -Rheumatoid arthritis For in vitro diagnostic use only. For professional use only.

SAA Rapid Quantitative Test (Chemiluminescence Immunoassay)

SAA Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Serum amyloid A (SAA) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of inflammation diseases.

NGAL Rapid Quantitative Test

NGAL (neutrophil gelatinase-associated lipocalin, lipocalin-2, sidero- calin) is a novel biomarker for diagnosing acute kidney injury (AKI). Under normal conditions NGAL levels are low in urine and plasma Still, they rise sharply from basal levels in response to kidney injury to reach diagnostic levels within a very short time - as much as 24 hours or more before any signiﬁcant rise in serum creatinine.

Product Name	SARS-COV-2 Neutralizing Antibody Rapid Test
Sample Type	Serum/Plasma
Loading Volume	80 uL
Reaction Time	10 min
Interpretation of Results	Negative: <1.5 IU/ml；Positive: ≥1.5 IU/ml
Shelf Life	24 months
Storage Condition	2-30℃
Unit	25 kits/box

Solutions

Covid-19 Solution

SARS-CoV-2 Neutralizing Antibody Rapid Test